23 October 2018

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT

Final Agenda 

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change before the meeting.

  1. Welcome and introduction to format of meeting – Part 1 only (open session)
  2. Code of conduct for members of the public attending the meeting – Part 1 only (open session)
  3. Apologies – Part 1 only (open session)
  4. Any other business – Part 1 only (open session)
  5. Appraisal of Nusinersen for treating spinal muscular atrophy [ID1069]
    • 5.1. Declarations of interest – Part 1 only (open session)
    • 5.2. Introduction by the Chair, Stephen O’Brien  Part 1 only (open session)
    • 5.3. Presentation by the Chair, Stephen O’Brien – Part 1 AND part 2 (open and closed session)
    • 5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  6. Appraisal of Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies [ID1166]
    • 6.1. Declarations of interest – Part 1 only (open session)
    • 6.2. Introduction by the Chair, Stephen O’Brien – Part 1 only (open session)
    • 6.3. Presentation by the Chair, Stephen O’Brien  Part 1 AND part 2 (open and closed session)
    • 6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  7. Appraisal of Regorafenib for previously treated hepatocellular carcinoma – rapid review of TA514 [ID1519] 

    Rapid reviews are treated by NICE as commercial in confidence.  All matters about the proposed scheme will remain confidential unless the appraisal committee meeting results in a change to guidance recommendations. As a result this discussion will take place in a part 2 session (part 2 sessions are closed to public observers).

    • 7.1. Declarations of interest – Part 2 only (closed session)
    • 7.2. Introduction by the Chair, Stephen O’Brien  Part 2 only (closed session)
    • 7.3. Presentation by the Chair, Stephen O’Brien  Part 2 only (closed session)
    • 7.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)

To print an agenda, please right click and select 'Print' from the menu.

Date, time and venue of next meeting

The next meeting will take place on Tuesday 27 November 2018 at 10:00am, NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT

Please note all timings are approximate.

How to register

  • Click on the register link below and complete the registration form, selecting the topics you would like to attend.
  • You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.
  • Registration will close on Tuesday 9 October 2018Please note that it may not be possible to accept late requests. 
  • Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Sandra Robinson.
  • Registrants wishing to conduct a research study on committee meetings and/or NICE processes will require prior permission. Contact the NICE Enquiry Handling team at nice@nice.org.uk.
  • Further information about conducting research is also available in our common questions and answers about meetings in public document.

 

Registration period: 25 September 2018 to 09 October 2018
Registration is closed.